通过PARP抑制剂诱导自是治疗效益的目标吗?
Ahmed M Elshazly1,2, Tuong Vi V Nguyen1, David A Gewirtz1
1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, 23298, USA.
Oncology research
|June 12, 2023
概括
多 (ADP-ribose) 聚合酶 (PARP) 抑制剂在癌症治疗中表现有前途,但可以产生耐药性. 本综述探讨了自性如何影响PARP抑制剂的有效性和耐药性,建议将自性向作为潜在的治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- PARP 抑制剂对具有 DNA 修复缺陷的恶性瘤有效.
- 对PARP抑制剂的耐药性是一个重大的临床挑战.
- 众所周知,PARP抑制剂可诱导细胞自,即细胞降解过程.
研究的目的:
- 审查对对PARP抑制剂的反应中自的多方面的作用.
- 探索向自的潜力,以提高PARP抑制剂的疗效.
- 通过自调节来研究克服PARP抑制剂耐药性的策略.
主要方法:
- 关于PARP抑制剂和自的研究的文献综述.
- 对自的细胞保护和细胞毒性功能的分析.
- 探索临床数据和临床前研究.
主要成果:
- 在PARP抑制的背景下,自可以是保护性的和有害的.
- PARP 抑制剂始终会诱导自.
- 自的具体作用 (细胞保护性与细胞毒性) 取决于细胞环境.
结论:
- 自在调解对PARP抑制剂的反应和抵抗方面发挥着复杂的作用.
- 向自可能是改善PARP抑制剂治疗的可行策略.
- 需要进一步的研究来阐明在癌症治疗中调节自的最佳方法.
相关概念视频
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


